This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Drug Therapy, Other  • Radiation Therapy  • Glaucoma  • Ocular/ Adnexal Tumors  • Drug Therapy  • Alert me on articles by topic

Carlos Bianciotto, MD; Carol L. Shields, MD; Brian Kang, BS; Jerry A. Shields, MD

Arch Ophthalmol. 2008;126(4):578-579.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Iris melanoma is uncommon, representing only 2% of all uveal melanomas.¹ In a series of 169 consecutive patients with iris melanoma, Shields et al² indicated that elevated intraocular pressure was found in 30% of cases. The main mechanism for the elevated pressure was mechanical obstruction of aqueous outflow from solid tumor or seeding. In that series, there were no eyes with secondary neovascular glaucoma. We report herein the unique association of neovascular glaucoma with chronic iris melanoma and discuss its management.

Report of a Case

A 64-year-old man was referred with a documented 12-year history of a slowly enlarging pigmented iris lesion in the left eye. The right eye had longstanding poor vision secondary to ocular histoplasmosis with a foveal scar diagnosed at age 15 years. At his initial visit, the visual acuities were 20/300 OD and 20/150 OS. On . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION